Carlson Capital L.P. Buys 46,555 Shares of The Clorox Company $CLX

Carlson Capital L.P. grew its position in shares of The Clorox Company (NYSE:CLX – Free Report) by 53.6% during the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 133,410 shares of the company’s stock after acquiring an additional 46,555 shares during the quarter. Clorox makes up 2.2% of Carlson Capital L.P.’s holdings, making the stock its 15th largest holding. Carlson Capital L.P.’s holdings in Clorox were worth $10,808,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently modified their holdings of CLX. NewEdge Advisors LLC boosted its position in Clorox by 11.8% in the second quarter. NewEdge Advisors LLC now owns 75,135 shares of the company’s stock worth $7,171,000 after purchasing an additional 7,956 shares during the last quarter. Public Employees Retirement System of Ohio bought a new stake in shares of Clorox during the 2nd quarter valued at about $3,277,000. Corient Private Wealth LP bought a new stake in shares of Clorox during the 2nd quarter valued at about $6,621,000. Allen Mooney & Barnes Investment Advisors LLC increased its position in shares of Clorox by 3,309.3% during the 3rd quarter. Allen Mooney & Barnes Investment Advisors LLC now owns 186,316 shares of the company’s stock valued at $15,093,000 after purchasing an additional 180,851 shares during the last quarter. Finally, Bank of America Corp DE increased its position in shares of Clorox by 6.1% during the 1st quarter. Bank of America Corp DE now owns 1,405,774 shares of the company’s stock valued at $145,680,000 after purchasing an additional 80,618 shares during the last quarter. 78.53% of the stock is currently owned by hedge funds and other institutional investors.

Clorox Stock Performance

NYSE:CLX opened at $109.35 on Monday. The company has a debt-to-equity ratio of 32.91, a quick ratio of 0.39 and a current ratio of 0.65. The stock has a 50-day simple moving average of $88.75 and a two-hundred day simple moving average of $99.54. The firm has a market capitalization of $13.25 billion, a PE ratio of 19.67, a P/E/G ratio of 3.46 and a beta of 0.59. The Clorox Company has a 52-week low of $79.12 and a 52-week high of $128.90.

Clorox (NYSE:CLX – Get Free Report) last released its earnings results on Monday, November 2nd. The company reported $1.55 EPS for the quarter, topping analysts’ consensus estimates of $1.07 by $0.48. Clorox had a net margin of 9.41% and a return on equity of 608.30%. The company had revenue of $1.91 billion for the quarter, compared to analysts’ expectations of $1.88 billion. During the same quarter last year, the business earned $0.85 EPS. The firm’s revenue was up 33.3% compared to the same quarter last year. Analysts forecast that The Clorox Company will post 5.74 EPS for the current year.

Clorox Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, November 13th. Stockholders of record on Wednesday, October 28th were paid a $1.25 dividend. The ex-dividend date of this dividend was Wednesday, October 28th. This represents a $5.00 dividend on an annualized basis and a dividend yield of 4.6%. Clorox’s dividend payout ratio is 89.93%.

Insider Activity

In other news, Director Pierre Breber acquired 4,000 shares of the firm’s stock in a transaction dated Wednesday, November 4th. The shares were purchased at an average cost of $100.06 per share, for a total transaction of $400,240.00. Following the transaction, the director directly owned 22,000 shares of the company’s stock, valued at approximately $2,201,320. This trade represents a 22.22% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.51% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on the stock. TD Cowen reiterated a “hold” rating on shares of Clorox in a research note on Tuesday, November 3rd. Evercore upgraded shares of Clorox from an “underperform” rating to a “hold” rating and set a $99.00 target price for the company in a research report on Monday, November 2nd. Jefferies Financial Group cut shares of Clorox from a “buy” rating to a “hold” rating and reduced their target price for the company from $125.00 to $98.00 in a report on Tuesday, July 28th. Morgan Stanley increased their price target on shares of Clorox from $87.00 to $94.00 and gave the stock an “equal weight” rating in a research report on Wednesday, November 4th. Finally, JPMorgan Chase & Co. increased their price target on shares of Clorox from $83.00 to $86.00 and gave the stock an “underweight” rating in a research report on Tuesday, November 3rd. One equities research analyst has rated the stock with a Buy rating, eleven have given a Hold rating and four have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Reduce” and a consensus price target of $93.79.

Read Our Latest Stock Analysis on Clorox

Clorox Profile

(Free Report)

The Clorox Company is a consumer products company founded in 1913 and headquartered in Oakland, California. It makes and markets products for household cleaning, food, water filtration, personal care and pet care. Its portfolio includes Clorox disinfecting and cleaning products, Glad trash bags and food-storage products, Kingsford charcoal, Brita water filters, Hidden Valley dressings and sauces, Burt’s Bees personal-care products, and Fresh Step cat litter. The company also sells products under brands such as Pine-Sol and Liquid-Plumr.

Featured Stories

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.